Introducing our new and improved Hot Tort Report
Being industry experts, we pride ourselves on keeping our finger on the pulse of all things Multi District Litigation. This predominantly consists of providing our subscribers with competitive insights into where the money is being spent in hopes of informing your blueprint for advertising strategies. These cases can be highly lucrative, but are difficult to acquire, requiring significant investment and patience to secure high-value cases.
We’ve been working hard on an algorithm to deliver more than just monthly TV spends and are proud to announce that we are ready to unveil our HTR 2.0.
This new list offers an overview of dollars spent across TV, Meta, PPC, and more, assigning a score to each tort based on what we, as leaders in the law firm advertising space, are witnessing across these various platforms.
The Hot Tort Report:
July 2025
The Hottest in Mass Tort Spending: June 2025
Birth Control Injections
Featured Tort
Subscribe to the Hot Tort Report
What’s the Tort News?
Published: July, 2025. Advertising spend from multiple sources for a recent 30 day period.
If you have any questions, please contact us at national@whitehardt.com
#1 Birth Control Injections
The Birth Control Injections mass tort holds onto the top spot this month with a total score of 11, continuing its dominance in the rankings. A slight drop in WHii was offset by rising Meta activity and consistently high TV spending. This tort continues to gain definition as the legal landscape evolves.
The federal MDL has grown to over 400 cases, with more than 10 million pages of documents produced and preemption arguments scheduled for September. This mass tort is moving rapidly, and Whitehardt understands how to help law firms break into this complex and competitive space.
CPA: $1,364 – $4,890
CPL: $682 – $2,445
For common criteria, please contact us.
#2 Roundup®
The Roundup® mass tort climbs from #4 to #2 this month with a 1.6-point gain, driven by renewed WHii and TV activity. The lift follows a recently published animal study suggesting a possible link between glyphosate exposure and Parkinsonian symptoms, adding fuel to existing concerns about the chemical’s long-term health effects.
This tort is still competing with BCI for #1. Whitehardt can help your firm stay ahead of the curve by crafting campaigns that connect with audiences suffering from the health effects of Roundup®.
CPA: $1,238
CPL: $743
For common criteria, please contact us.
#3 Paraquat
The Paraquat mass tort jumps 2.9 points this month, climbing into the #3 spot after steady gains in WHii and Meta activity. Though TV remains inactive, digital traction continues to drive this tort’s upward momentum.
In the litigation, over 6,250 cases are active in the federal MDL, which is in the midst of settlement discussions.
With increasing digital visibility and mounting pressure for resolution, Paraquat remains a strong contender. Whitehardt is ready to help your firm build a campaign strategy that accounts for the evolving legal landscape and emerging opportunities in this tort.
CPA: $653
CPL: $294
Common Criteria: Diagnosis of Parkinson’s Disease or experiencing Parkinson’s-like symptoms after exposure to Paraquat.
#5 Video Game Addiction
Video Game Addiction holds its ground in the top 5 despite a 1.3-point drop this month, driven by a decline in WHii. Meta and PPC remain strong, keeping this mass tort highly visible across digital channels. With growing scientific validation of the public health impacts of Internet Gaming Disorder (IGD), this litigation is poised to evolve. Let us help your firm take a data-informed approach to connecting with affected families.
CPA: $367
CPL: $169
Common Criteria: Child must be under 18 and spend 4+ hours per day, 5+ days per week, playing Minecraft, Fortnite, GTA 5, or Call of Duty. The child must also experience one or more of the following: addiction, poor school performance, school dropout, cognitive or developmental delays, chronic depression or anxiety, or self-harm/suicidal behavior.
#6 Birth Injury
Birth Injury holds steady at #6 this month. A very slight drop in Meta is the only movement across channels, while TV and PPC remain unchanged. This consistency reflects the tort’s ongoing relevance and the stable demand for firms positioned to support families through these life-altering cases. Whitehardt can help you maintain visibility and compassion in this competitive space with targeted, trust-building campaigns.
For metrics such as CPA, CPL, and common criteria, please contact us.
#7 Ultra-Processed Foods
The Ultra-Processed Foods mass tort drops to #7 in July, down from #3 last month, following declines in WHii and TV activity, though Meta saw a slight uptick. Despite the score dip, public interest remains high as national media and new studies continue to expose the potential health dangers of UPFs.
With litigation strategies drawing comparisons to Big Tobacco and mounting evidence linking these foods to cardiometabolic risk, this tort still shows long-term potential.
For metrics such as CPA, CPL, and common criteria, please contact us.
#9 Diabetes Meds for Weight Loss
The Diabetes Meds for Weight Loss tort climbs into the top ten at #9 with a 1-point rise in WHii. Despite zero TV spending, persistent public attention and digital chatter around GLP-1 class medications are keeping it afloat. If you’re looking to engage audiences where the demand already exists, Whitehardt can help you capitalize on the momentum.
CPA: $156 – $224
CPL: $78 – $112
Common Criteria: Took a prescription diabetes drug for weight loss (e.g. Ozempic, Mounjaro); discontinued use of the drug; and experienced one or more gastrointestinal disorders at least 30 days after the first dose.
#10 AFFF
AFFF holds steady at #10 with no change to the scores across every channel. While momentum has neither risen nor fallen this month, its stability suggests an entrenched presence in the mass tort landscape. For firms already engaged or considering entry, this consistency may offer a reliable foundation as the litigation continues to develop.
CPA: $3,500
CPL: $1,750
For common criteria, please contact us.
Mesothelioma
You may be noticing a tort missing from our new report. While Mesothelioma continues to dominate the competition when it comes to spend levels, Whitehardt finds that this tort is its own niche animal. These cases can be extremely fruitful, but hard to come by, requiring a high buy-in to get in the game and patience when landing that ringer of a case. We believe that Meso will remain a constant for some time, but in regards to many of the other drugs and devices we focus on in this monthly report, we’ve decided to move it to its own category. If you are interested in hearing the latest news on Meso or how Whitehardt may be currently seeking these cases, you can contact us here.
Whitehardt will continue to track meso spending from month to month, so if you are interested in ongoing meso spending, please reach out to us directly. Going forward, we will be excluding meso from these tort reports.
#8 Social Media
The Social Media mass tort enters the top ten in July after narrowly missing the cut last month. A WHii surge helped propel it into #8, even as Meta saw a dip and TV spending held at zero. With online conversations driving awareness around mental health harms linked to social platforms, firms may find an opportunity here without relying on traditional media. Whitehardt can help you harness organic momentum and turn it into case volume.
For metrics such as CPA, CPL, and common criteria, please contact us.